Latest News:

Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®

Quotient Clinical CEO Mark Egerton a winner at UK EY Entrepreneur of the Year 2015 awards

6th October 2015

Mark Egerton winning awardQuotient Clinical has announced that CEO Mark Egerton has received an EY Entrepreneur of the Year® 2015 UK Award. Chosen by a panel of independent judges, the award acknowledges outstanding entrepreneurs who demonstrate excellence and extraordinary success in areas such as innovation, financial performance and personal commitment to their businesses and communities.

Dr Egerton was one of 13 business leaders recognised for their achievements, and received his award at a special dinner held at The Brewery, London on the 5th of October.

Dr Egerton commented: “I am delighted to receive this honour in recognition of the high level of success that Quotient Clinical has achieved in recent years. The award acknowledges all of the hard work and dedication from everyone within the company. Thanks to an incredible team, we have repeatedly demonstrated that Translational Pharmaceutics® can deliver significant time and cost savings for our customers, helping them to increase their overall R&D productivity.”

Download a PDF version – EY National Entrepreneur of the Year

For further information, please contact:EY entrepreneur of the year award

Robin Bodicoat
Marketing Director
Quotient Clinical
Tel: +44 (0)115 931 5102
robin.bodicoat@quotientclinical.com

 

News

Read related news

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.